Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 7, 2022 | Series A | — | 10 | Xiamen Jinyuan Venture Capital China Singapore Suzhou Industrial Park Ventures Eli Lilly Qiming Venture Partners | — | Detail |
Sep 8, 2021 | Seed | ¥77M | 7 | Lilly Asia Ventures Qiming Venture Partners Sequoia Capital China | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Xiamen Jinyuan Venture Capital | Yes | Series A |
China Singapore Suzhou Industrial Park Ventures | Yes | Series A |
Eli Lilly | Yes | Series A |
Qiming Venture Partners | Yes | Series A |
Lilly Asia Ventures | Yes | Seed |
Trip Capital | — | Series A |
Founder H Fund | — | Series A |
FREES FUND | — | Series A |
Junsan Capital | — | Series A |
Oriza Holdings | — | Series A |